Oxathiolanes
AssigneeState of Israel, Israel Institute of Biological Research
InventorsAbraham Fisher, Ishai Karton
Life of this patent
Estimating the term…
Loading patent…
AssigneeState of Israel, Israel Institute of Biological Research
InventorsAbraham Fisher, Ishai Karton
Estimating the term…
The present invention accordingly provides in one aspect, novel spiro-oxathiolane/quinuclidine compounds corresponding with the schematic structural formula (I) ##STR1## and geometrical isomers, enantiomers, diastereoisomers, racemates and acid addition salts thereof, wherein one of Y and Z is 0 and the other is S(.dbd.O).sub.n ; n is 0, 1 or 2; R' and R" are each selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, hydroxyalkyl, aminoalkyl, C.sub.3-7 cycloalkyl, aryl, diarylmethylol, and alkyl substituted by at least one aryl group, provided that at least R' and R" is other than hydrogen; and each X is hydrogen, or when Y is 0 and Z is S(.dbd.O).sub.n simultaneously, then each X may also be selected from the group consisting of deuterium and tritium, and provided further that when each X is hydrogen, Y is 0 and Z is S simultaneously, then at least one of R' and R" is selected from the group consisting of alkenyl, alkynyl, cyclopropyl, cyclobutyl, cycloheptyl, hydroxyalkyl and aminoalkyl.
A compound of the formula (I) ##STR4## and geometrical isomers, enantiomers, diastereoisomers, racemates and acid addition salts thereof, wherein one of Y and Z is O and the other is S(.dbd.O).sub.n ;
A pharmaceutical composition for use in treating diseases of the central nervous system in mammals, which comprises:
Dependencies are inferred from the claim text.